Signal recognition particle (SRP) is a ubiquitous ribonucleoprotein complex that targets proteins to endoplasmic reticulum (ER) in eukaryotes. Here we report that Plasmodium falciparum SRP is composed of six polypeptides; SRP9, SRP14, SRP19, SRP54, SRP68 and SRP72 and a 303nt long SRP RNA. We generated four transgenic parasite lines expressing SRP-GFP chimeric proteins and co-localization studies showed the nucleo-cytoplasmic localization for these proteins. The evaluation of the effect of known SRP and nuclear import/export inhibitors on P. falciparum revealed that ivermectin, an inhibitor of importin α/β mediated nuclear import inhibited the nuclear import of PfSRP polypeptides at submicromolar concentration, thereby killing the parasites. These findings provide insights into dynamic structure of P. falciparum SRP and also raise the possibility that ivermectin could be used in combination with other antimalarial agents to control the disease.
Between 1983 and 1994, posterior cervical foraminotomy as described by Frykholm was performed on 89 patients with exclusively radicular symptoms caused by cervical osteophytes. The main presenting feature was arm pain. Objective neurological signs were present in 50% of the patients. At mean postoperative follow-up of 8.6 months, 95.5% of patients reported excellent or good results, while 4.5% were not improved. No patient was rendered worse following the procedure. There were no deaths and the complication rate was 2.2%. Further surgery for recurrent root symptoms was required by 6.7% of patients. Our findings are in keeping with the good results and low complication rate of this procedure as described in other studies. Informal inquiries suggest that this procedure is not widely used, at any rate in the United Kingdom, and we present this series in order to emphasize the efficacy and safety of this procedure.
Berberine (a protoberberine isoquinoline alkaloid) has shown promising pharmacological
activities, including analgesic, anti-inflammatory, anticancer, antidiabetic, anti-hyperlipidemic, cardioprotective,
memory enhancement, antidepressant, antioxidant, anti-nociceptive, antimicrobial, anti-
HIV and cholesterol-lowering effects. It is used in the treatment of the neurodegenerative disorder. It
has strong evidence to serve as a potent phytoconstituent in the treatment of various neurodegenerative
disorders such as AD. It limits the extracellular amyloid plaques and intracellular neurofibrillary tangles.
It has also lipid-glucose lowering ability, hence can be used as a protective agent in atherosclerosis
and AD. However, more detailed investigations along with safety assessment of berberine are warranted
to clarify its role in limiting various risk factors and AD-related pathologies. This review highlights
the pharmacological basis to control oxidative stress, neuroinflammation and protective effect of
berberine in AD, which will benefit to the biological scientists in understanding and exploring the new
vistas of berberine in combating Alzheimer’s disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.